- Home
- BMEA vs JSPR Comparison
BMEA vs JSPR Comparison
Compare BMEA & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- JSPR
- Stock Information
- Founded
- BMEA 2017
- JSPR 2018
- Country
- BMEA United States
- JSPR United States
- Employees
- BMEA N/A
- JSPR N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BMEA Health Care
- JSPR Health Care
- Exchange
- BMEA Nasdaq
- JSPR Nasdaq
- Market Cap
- BMEA 275.6M
- JSPR 302.0M
- IPO Year
- BMEA 2021
- JSPR N/A
- Fundamental
- Price
- BMEA $11.24
- JSPR $19.90
- Analyst Decision
- BMEA Buy
- JSPR Strong Buy
- Analyst Count
- BMEA 13
- JSPR 10
- Target Price
- BMEA $36.33
- JSPR $74.86
- AVG Volume (30 Days)
- BMEA 1.1M
- JSPR 367.5K
- Earning Date
- BMEA 11-01-2024
- JSPR 11-07-2024
- Dividend Yield
- BMEA N/A
- JSPR N/A
- EPS Growth
- BMEA N/A
- JSPR N/A
- EPS
- BMEA N/A
- JSPR N/A
- Revenue
- BMEA N/A
- JSPR N/A
- Revenue This Year
- BMEA N/A
- JSPR N/A
- Revenue Next Year
- BMEA N/A
- JSPR N/A
- P/E Ratio
- BMEA N/A
- JSPR N/A
- Revenue Growth
- BMEA N/A
- JSPR N/A
- 52 Week Low
- BMEA $3.61
- JSPR $4.00
- 52 Week High
- BMEA $22.74
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- BMEA 64.18
- JSPR 58.14
- Support Level
- BMEA $10.35
- JSPR $14.42
- Resistance Level
- BMEA $12.30
- JSPR $21.86
- Average True Range (ATR)
- BMEA 0.93
- JSPR 1.42
- MACD
- BMEA -0.01
- JSPR 0.50
- Stochastic Oscillator
- BMEA 47.26
- JSPR 73.66
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.